UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000007123
Receipt No. R000008389
Scientific Title A Phase II Study of Bevacizumab (Avastin®) in Combination with Standard Second line chemotherapy (Docetaxel Or Pemetrexed) in Patients with Non-Squamous Non-Small-Cell Lung Cancer previously Treated with chemotherapy
Date of disclosure of the study information 2012/02/01
Last modified on 2019/04/24 15:56:05

No. Disposal Last modified on Item of update
1 Insert 2012/01/23 20:52:37
2 Update 2019/04/24 14:49:02 UMIN ID1
3 Update 2019/04/24 15:56:05 Recruitment status
Date of IRB
Last follow-up date


Contact us.